Lucinda V. Jackson

Synthetic Route Design of AZD4635, an A2AR Antagonist

Andrew D. Campbell, Matthew Charles Evans, Staffan Karlsson, 2019 .

An Orally Bioavailable, Indole-3-glyoxylamide Based Series of Tubulin Polymerization Inhibitors Showing Tumor Growth Inhibition in a Mouse Xenograft Model of Head and Neck Cancer.

Lucinda V. Jackson, P. Lockey, D. Norman, 2015, Journal of Medicinal Chemistry.

Development and Scale-Up of an Improved Manufacturing Route to the ATR Inhibitor Ceralasertib

Lucinda V. Jackson, A. Dalgleish, Michael Popadynec, 2020, Organic Process Research & Development.

Development and Proof of Concept for a Large-Scale Photoredox Additive-Free Minisci Reaction

Lucinda V. Jackson, Chris D. Parsons, D. Whittaker, 2020, Organic Process Research & Development.

An Orally Bioavailable, Indole-3-glyoxylamide Based Series of Tubulin Polymerization Inhibitors Showing Tumor Growth Inhibition in a Mouse Xenograft Model of Head and Neck Cancer.

Lucinda V. Jackson, P. Lockey, D. Norman, 2015, Journal of Medicinal Chemistry.